AFT Pharmaceuticals

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Pharmaceutical company based in Australia and New Zealand with significant sales [circa $110M per annum]
Drug development working towards key products which are licensed in a number of countries around the world. Patented oral and IV Acetaminophen-Ibuprofen analgesic; Patent pending dermatology drug [orphan and general indications]; Patented drug delivery system to avoid intravenous route; 24hr acting hand sanitizer.
Licensing opportunities still available for selected territories including USA.
Ticker:
AFT.NZ and AFP.AX
Exchange:
NZX and ASX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
New Zealand
Year Founded:
1997
Main Therapeutic Focus:
Lead Product in Development:
Maxigesic, Pascomer, NasoSURF, Crystawash Extend
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker
photo
CEO
AFT Pharmaceuticals Inc.